MENU
X
Close Menu CLOSE
CREATE
TRANSFORMATIVE
MEDICINES
A global leader in innovative solutions for the discovery, development, and manufacture of novel nanoparticle medicines.
 
Every Stage
of Development

No two journeys are the same.

 

Finding trusted partners in the journey from discovery to clinical manufacturing becomes as critical as the journey itself.

 

PNI is uniquely positioned to offer the flexibility needed to move products from the clinical development stages through to commercial scale in a nimble and agile manner, accelerating the research and drug development process.

 

We provide a breadth of expertise in formulation and clinical solutions, a proprietary platform and reagents. We empower life science researchers and drug developers to create transformative medicines that significantly improve human well being.

 

Formulation Solutions Formulation Solutions Formulation Solutions
Thousands of compounds may be potential candidates for development as a medical treatment. Rapidly prepare low-volume nanoparticle formulations with the push of a button on the Spark™ or learn how Formulation Solutions can help with proof-of-concept nanoparticle formulations. Nanomedicine is playing a key role in pharmaceutical discovery, largely in the form of nanoparticle-based delivery systems for drugs.
After early testing, only a small number of compounds look promising and call for further study. In this stage, optimizing a wide range of nanomedicine formulations with the NanoAssemblr® Benchtop or the Blaze  depending on your volumes to allow you to gather the data on the effectiveness, required dosing and safety of a new therapy.
Develop nanoparticle drugs for clinical evaluation and to support clinical development for their commercialization. Scalable manufacturing is a significant challenge to making revolutionary medicine and Formulation Solutions is ready to assist you in your nanoparticle manufacturing process development. PNI provides a custom Clinical Solution for development and commercial supply.

Get Started

To learn how Precision NanoSystems accelerates nanomedicine development from an idea to clinical applications, contact our Technical Sales Team.

Get in Touch
Technology

Our technology provides a seamless path forward to larger experimental studies, all the way to the clinic: low volume prototype formulations are easily scaled-up using larger instruments of the NanoAssemblr® family, which provides microfluidic mixing and manufacturing of nanoparticles.

 


Mixtures
Areas of Interest
Nanomedicines span many areas of interest. Explore resources like papers, application notes, scientific posters, webinars and more to see how nanotechnology is transforming medicine. 
Particles
over
70%
of top pharmaceutical companies work with PNI
200+

instruments are installed

worldwide

80+
biopharmaceutical labs use NanoAssemblr® instruments for nanomedicine drug development
Innovations that accelerate the drug development journey and enable the production of more sophisticated and powerful nanomedicines is our passion. We don’t do it alone, we pursue strategic collaborations that enable researchers to move quickly in the drug development process. Contact our Business Development Team.

 

 

 

 

 

PNI Feature in BioWorld

 

"As we bite off different problems and succeed on those, we can leverage those technologies," CEO Taylor explains. "We like to think that we're democratizing and lowering the barrier for people to get into these important technologies."

Evonik Collaboration

 

PNI announces a manufacturing collaboration agreement with Evonik for the tech transfer of the NanoAssemblr system to Evonik Canada for late-stage clinical research.

Record Growth in 2017

 

19 of the top 25 pharmaceutical companies use the NanoAssemblr™ platform and PNI’s technology was featured in 100+ peer-reviewed publications.

 

Upcoming Events See All

September
21 - 24
2018

International Nanomedicine & Drug Delivery Symposium (NANODDS)

The objectives of this symposium are to highlight new groundbreaking discoveries and developments in nanomedicine and drug delivery. Revolutionary advances in this area require collaboration among researchers working in a diverse array of fields including nanotechnology, materia...



Visit Event Website

September 30 -
October 04
2018

Annual Meeting of the Oligonucleotide Therapeutics Society (OTS)

Join leading experts in the field at the OTS Annual Meeting which will feature the latest developments from the various oligonucleotide-based disciplines.



Visit Event Website

October
09 - 12
2018

CphI Worldwide

The exhibition showcases cover the whole spectrum of pharmaceutical manufacturing and ingredients sourcing, offering products and services that cover the entire supply chain.



Visit Event Website

Resource Center

Poster

July 01, 2018

Robust low-volume production of nanoparticles for genetic manipulation of cells

Read More PDF

Application Note

July 01, 2018

Seamless scale up of liposomal verteporfin formulations using the NanoAssemblr® Platform

Read More PDF

Publication - Abstract

April 26, 2018

Small Methods

State‐of‐the‐Art Design and Rapid‐Mixing Production Techniques of Lipid Nanoparticles for Nucleic Acid Delivery

Evers, M. J. W., Kulkarni, J. A., van der Meel, R., Cullis, P. R., Vader, P., & Schiffelers, R. M.

Read More

Publication - Abstract

February 27, 2018

Cell Reports

A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing

J. Finn, A. Smith, M. Patel, L. Shaw, M. Youniss, J. Heteren, T. Dirstine, C. Ciullo, R. Lescarbeau, J. Seitzer, R. Shah...

Read More

Video

September 14, 2018

From Concept to Reality: Development of Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics - Martin Maier, Alnylam

Read More

Poster

August 04, 2018

Microfluidic Manufacture of PLGA Nano and Microparticle Drug Delivery Vehicles

Read More PDF
Resource Center

Stay Informed

Sign up today to automatically receive new Precision NanoSystems application notes, conference posters, relevant science publications, and webinar invites.